You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Sanofi and IGM Biosciences team up to develop antibody agonists

Sanofi and IGM have announced the signing of a collaboration agreement to create, develop, manufacture and commercialise IgM antibody agonists against three oncology and three immunology/inflammation targets.